Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist

B. W. van Oosten*, J. Killestein, E. M H Mathus-Vliegen, C. H. Polman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Laboratory research including animal models of human disease suggests that cannabinoids might have therapeutic potential in multiple sclerosis (MS). We have recently seen a 46-year-old woman who developed MS after starting treatment with a cannabinoid receptor antagonist for obesity. The occurrence of MS several months after starting a cannabinoid receptor antagonist suggests that the cannabinoid system might indeed be relevant to disease pathogenesis in MS.

Original languageEnglish
Pages (from-to)330-331
Number of pages2
JournalMultiple Sclerosis
Volume10
Issue number3
DOIs
Publication statusPublished - 1 Jun 2004

Cite this